In a companion animal study, your patient can’t tell you whether the treatment worked. The only read on whether a drug is doing its job comes from an owner watching at home, which makes your endpoint the most fragile part of the whole study.
Get it wrong, and a drug that genuinely works can still fail to show it.
On June 30, Tommy Jackson sat down with Lesley Rausch-Derra, DVM, a drug developer who has taken owner-reported endpoints through FDA approval, to dig into how you build one that holds up.
In this session, we covered:
What makes an owner questionnaire strong enough to build a study on
How to keep owner-collected data clean, and get a regulator to accept it
Where wearables and objective measures actually help, and where they don’t
Originally aired Tuesday, June 30 | 10:00 AM Central Time | 45 minutes
Fill out the form to watch the full replay.